Literature DB >> 29605836

Structure and function of anticoagulation clinics in the United States: an AC forum membership survey.

Geoffrey D Barnes1, Eva Kline-Rogers2, Christopher Graves2, Eric Puroll2, Xiaokui Gu2, Kevin Townsend3, Ellen McMahon3, Terri Craig3, James B Froehlich2.   

Abstract

Many anticoagulation clinics have adapted their services to provide care for patients taking direct oral anticoagulants (DOAC) in addition to traditional warfarin management. Anticoagulation clinic scope of service and operations in this transitional environment have not been well described in the literature. A survey was conducted of United States-based Anticoagulation Forum members to inquire about anticoagulation clinic structure, function, and services provided. Survey responses are reported using summary or non-parametric statistics, when appropriate. Unique clinic survey responses were received from 159 anticoagulation clinics. Clinic structure and staffing are highly variable, with approximately half of clinics (52%) providing DOAC-focused care in addition to traditional warfarin-focused care. Of those clinics managing DOAC patients, this accounts for only 10% of their clinic volume. These clinics commonly have a DOAC follow up protocol (75%). Clinics assign a median of 190.5 (interquartile range 50-300) patients per staff full-time-equivalent, with more patients assigned in phone-based care clinics than in face-to-face based care clinics. Most clinics (68.5%) report receiving reimbursement, which occur either through a combination of patient and insurance provider billing (78.2%), insurance reimbursement only (19.5%) or patient reimbursement only (2.3%). There is wide heterogeneity in anticoagulation clinic structure, function, and services provided. Half of all survey-responding anticoagulation clinics provide care for DOAC-treated patients. Understanding how changes in healthcare policy and reimbursement have impacted these clinics remains to be explored.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29605836     DOI: 10.1007/s11239-018-1652-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

1.  Comparison of two different models of anticoagulation management services with usual medical care.

Authors:  Kelly M Rudd; John G Dier
Journal:  Pharmacotherapy       Date:  2010-04       Impact factor: 4.705

Review 2.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes.

Authors:  Laura G Stoudenmire; Christina E DeRemer; Hazem Elewa
Journal:  Int J Hematol       Date:  2014-06-21       Impact factor: 2.490

Review 4.  Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management.

Authors:  J E Ansell; R Hughes
Journal:  Am Heart J       Date:  1996-11       Impact factor: 4.749

5.  Do specialty anticoagulation clinics really outperform primary care at INR management?

Authors:  Scott R Garrison; G Michael Allan
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

6.  Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.

Authors:  Benjamin A Steinberg; Peter Shrader; Laine Thomas; Jack Ansell; Gregg C Fonarow; Bernard J Gersh; Peter R Kowey; Kenneth W Mahaffey; Gerald Naccarelli; James Reiffel; Daniel E Singer; Eric D Peterson; Jonathan P Piccini
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

Review 7.  A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.

Authors:  Taher Entezari-Maleki; Samaneh Dousti; Hadi Hamishehkar; Kheirollah Gholami
Journal:  J Clin Pharmacol       Date:  2015-09-21       Impact factor: 3.126

8.  The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.

Authors:  Geoffrey D Barnes; Xiaokui Gu; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Dennis Besley; Gregory D Krol; James B Froehlich; Scott Kaatz
Journal:  Thromb Res       Date:  2014-06-02       Impact factor: 3.944

9.  Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants.

Authors:  Geoffrey D Barnes; Brahmajee K Nallamothu; Anne E Sales; James B Froehlich
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-03-01

Review 10.  Anticoagulation clinic versus a traditional warfarin management model.

Authors:  Tammy L McGuinn; Susan Scherr
Journal:  Nurse Pract       Date:  2014-10-15
View more
  6 in total

Review 1.  Stroke and thromboembolism prevention in atrial fibrillation.

Authors:  Sina Jame; Geoffrey Barnes
Journal:  Heart       Date:  2019-09-18       Impact factor: 5.994

2.  Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed-methods study.

Authors:  Geoffrey D Barnes; Jennifer Acosta; Christopher Graves; Eric Puroll; Eva Kline-Rogers; Xiaokui Gu; Kevin Townsend; Ellen McMahon; Terri Craig; James B Froehlich
Journal:  Res Pract Thromb Haemost       Date:  2018-10-19

3.  Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial.

Authors:  Jacob E Kurlander; Danielle Helminski; Michael Lanham; Jennifer L Henstock; Kelley M Kidwell; Sarah L Krein; Sameer D Saini; Caroline R Richardson; Raymond De Vries; Kenneth Resnicow; Allison Laboon Ruff; David M Wallace; Elizabeth K Jones; Linda K Perry; Jacqueline Parsons; Nghi Ha; Tina Alexandris-Souphis; Dale Dedrick; Elizabeth Aldridge; Geoffrey D Barnes
Journal:  Implement Sci Commun       Date:  2022-01-28

4.  Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.

Authors:  Osvaldo Ulises Garay; Gonzalo Guiñazú; Yolanda Patricia Adamczuk; Cristina Duboscq
Journal:  Pharmacoecon Open       Date:  2022-07-14

5.  Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process.

Authors:  Henry Han; Grace Chung; Emily Sippola; Wilson Chen; Spencer Morgan; Elizabeth Renner; Allison Ruff; Anne Sales; Jacob Kurlander; Geoffrey D Barnes
Journal:  Res Pract Thromb Haemost       Date:  2021-07-16

6.  Community-acquired and hospital-acquired medication harm among older inpatients and impact of a state-wide medication management intervention.

Authors:  Karen Pellegrin; Alicia Lozano; Jill Miyamura; Joanne Lynn; Les Krenk; Sheena Jolson-Oakes; Anita Ciarleglio; Terry McInnis; Alistair Bairos; Lara Gomez; Mercedes Benitez-McCrary; Alexandra Hanlon
Journal:  BMJ Qual Saf       Date:  2018-10-18       Impact factor: 7.035

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.